Original Research Article · e0006
Development of a technology for producing medicated lozenges with carbon dioxide extracts of Acorus calamus L. rhizomes and Calendula officinalis L. flowers
Full text in three languages: Русский · Қазақша · English
Ibadullayeva G.S.. Development of a technology for producing medicated lozenges with carbon dioxide extracts of Acorus calamus L. rhizomes and Calendula officinalis L. flowers. Pharmaceutical Sciences and Health Products. 2026;1(2):e0006.
Abstract
Introduction
Medicated lozenges are solid unit-dose dosage forms intended to dissolve slowly in the oral cavity and pharynx, thereby providing prolonged contact of active components with the mucosa. The incorporation of plant extracts into medicated lozenges is of interest in the development of locally acting products; in this context, particular importance is attached to establishing process parameters that provide a stable technological mass and enable its subsequent moulding.
Objective
To develop a technology for producing medicated lozenges containing carbon dioxide extracts of Acorus calamus L. rhizomes and Calendula officinalis L. flowers.
Materials and methods
Thick carbon dioxide extracts of Acorus calamus L. rhizomes (batch AC 0103.2024) and Calendula officinalis L. flowers (batch CO 0103.2024), manufactured by PLP Zhanafarm LLP, were used as the plant components. The excipients were sugar, isomalt, glucose syrup, glycerol, citric acid, food colour and purified water. The laboratory process comprised preparation of the starting components, preparation of the base under heating and mixing, incorporation of the plant extracts, production of a homogeneous mass, cooling and casting into moulds. Dosing accuracy, operation temperature and duration, residual moisture, mass homogeneity and moulding parameters were monitored.
Results
The working ranges of the principal process parameters were established: 135–140 °C for preparation of the carbohydrate base, 115–120 °C for glycerol incorporation, 80–85 °C for incorporation of the carbon dioxide extracts, 15–25 rpm for mixing and 15–20 min at 5 °C for cooling. When residual moisture of the lozenge mass was reduced to approximately 1%, the technological properties required for casting were achieved. The mass of one lozenge was 0.6 g. The sequence of the main operations and the parameters to be controlled were specified.
Conclusion
A laboratory technology was developed for producing medicated lozenges containing carbon dioxide extracts of Acorus calamus L. rhizomes and Calendula officinalis L. flowers on a sugar-isomalt base with glucose syrup. Working ranges were established experimentally for preparation of the carbohydrate base, incorporation of glycerol and plant extracts, mixing, moulding and cooling. The findings provide a basis for a laboratory process scheme and may be used in developing a manufacturing procedure for the lozenges.
Keywords
Article history
- Published
- Revised PDF layout introduced; scientific content unchanged.
- PDF before the layout revision · PDF with revised layout
Peer-review model: Double-blind external peer review · Version: Version of Record
Supplementary materials
No separate supplementary materials.